Introduction – Company Background

GuangXin Industrial Co., Ltd. is a specialized manufacturer dedicated to the development and production of high-quality insoles.

With a strong foundation in material science and footwear ergonomics, we serve as a trusted partner for global brands seeking reliable insole solutions that combine comfort, functionality, and design.

With years of experience in insole production and OEM/ODM services, GuangXin has successfully supported a wide range of clients across various industries—including sportswear, health & wellness, orthopedic care, and daily footwear.

From initial prototyping to mass production, we provide comprehensive support tailored to each client’s market and application needs.

At GuangXin, we are committed to quality, innovation, and sustainable development. Every insole we produce reflects our dedication to precision craftsmanship, forward-thinking design, and ESG-driven practices.

By integrating eco-friendly materials, clean production processes, and responsible sourcing, we help our partners meet both market demand and environmental goals.

Core Strengths in Insole Manufacturing

At GuangXin Industrial, our core strength lies in our deep expertise and versatility in insole and pillow manufacturing. We specialize in working with a wide range of materials, including PU (polyurethane), natural latex, and advanced graphene composites, to develop insoles and pillows that meet diverse performance, comfort, and health-support needs.

Whether it's cushioning, support, breathability, or antibacterial function, we tailor material selection to the exact requirements of each project-whether for foot wellness or ergonomic sleep products.

We provide end-to-end manufacturing capabilities under one roof—covering every stage from material sourcing and foaming, to precision molding, lamination, cutting, sewing, and strict quality control. This full-process control not only ensures product consistency and durability, but also allows for faster lead times and better customization flexibility.

With our flexible production capacity, we accommodate both small batch custom orders and high-volume mass production with equal efficiency. Whether you're a startup launching your first insole or pillow line, or a global brand scaling up to meet market demand, GuangXin is equipped to deliver reliable OEM/ODM solutions that grow with your business.

Customization & OEM/ODM Flexibility

GuangXin offers exceptional flexibility in customization and OEM/ODM services, empowering our partners to create insole products that truly align with their brand identity and target market. We develop insoles tailored to specific foot shapes, end-user needs, and regional market preferences, ensuring optimal fit and functionality.

Our team supports comprehensive branding solutions, including logo printing, custom packaging, and product integration support for marketing campaigns. Whether you're launching a new product line or upgrading an existing one, we help your vision come to life with attention to detail and consistent brand presentation.

With fast prototyping services and efficient lead times, GuangXin helps reduce your time-to-market and respond quickly to evolving trends or seasonal demands. From concept to final production, we offer agile support that keeps you ahead of the competition.

Quality Assurance & Certifications

Quality is at the heart of everything we do. GuangXin implements a rigorous quality control system at every stage of production—ensuring that each insole meets the highest standards of consistency, comfort, and durability.

We provide a variety of in-house and third-party testing options, including antibacterial performance, odor control, durability testing, and eco-safety verification, to meet the specific needs of our clients and markets.

Our products are fully compliant with international safety and environmental standards, such as REACH, RoHS, and other applicable export regulations. This ensures seamless entry into global markets while supporting your ESG and product safety commitments.

ESG-Oriented Sustainable Production

At GuangXin Industrial, we are committed to integrating ESG (Environmental, Social, and Governance) values into every step of our manufacturing process. We actively pursue eco-conscious practices by utilizing eco-friendly materials and adopting low-carbon production methods to reduce environmental impact.

To support circular economy goals, we offer recycled and upcycled material options, including innovative applications such as recycled glass and repurposed LCD panel glass. These materials are processed using advanced techniques to retain performance while reducing waste—contributing to a more sustainable supply chain.

We also work closely with our partners to support their ESG compliance and sustainability reporting needs, providing documentation, traceability, and material data upon request. Whether you're aiming to meet corporate sustainability targets or align with global green regulations, GuangXin is your trusted manufacturing ally in building a better, greener future.

Let’s Build Your Next Insole Success Together

Looking for a reliable insole manufacturing partner that understands customization, quality, and flexibility? GuangXin Industrial Co., Ltd. specializes in high-performance insole production, offering tailored solutions for brands across the globe. Whether you're launching a new insole collection or expanding your existing product line, we provide OEM/ODM services built around your unique design and performance goals.

From small-batch custom orders to full-scale mass production, our flexible insole manufacturing capabilities adapt to your business needs. With expertise in PU, latex, and graphene insole materials, we turn ideas into functional, comfortable, and market-ready insoles that deliver value.

Contact us today to discuss your next insole project. Let GuangXin help you create custom insoles that stand out, perform better, and reflect your brand’s commitment to comfort, quality, and sustainability.

🔗 Learn more or get in touch:
🌐 Website: https://www.deryou-tw.com/
📧 Email: shela.a9119@msa.hinet.net
📘 Facebook: facebook.com/deryou.tw
📷 Instagram: instagram.com/deryou.tw

Graphene insole manufacturer in China

Are you looking for a trusted and experienced manufacturing partner that can bring your comfort-focused product ideas to life? GuangXin Industrial Co., Ltd. is your ideal OEM/ODM supplier, specializing in insole production, pillow manufacturing, and advanced graphene product design.

With decades of experience in insole OEM/ODM, we provide full-service manufacturing—from PU and latex to cutting-edge graphene-infused insoles—customized to meet your performance, support, and breathability requirements. Our production process is vertically integrated, covering everything from material sourcing and foaming to molding, cutting, and strict quality control.High-performance graphene insole OEM Indonesia

Beyond insoles, GuangXin also offers pillow OEM/ODM services with a focus on ergonomic comfort and functional innovation. Whether you need memory foam, latex, or smart material integration for neck and sleep support, we deliver tailor-made solutions that reflect your brand’s values.

We are especially proud to lead the way in ESG-driven insole development. Through the use of recycled materials—such as repurposed LCD glass—and low-carbon production processes, we help our partners meet sustainability goals without compromising product quality. Our ESG insole solutions are designed not only for comfort but also for compliance with global environmental standards.China high-end foam product OEM/ODM

At GuangXin, we don’t just manufacture products—we create long-term value for your brand. Whether you're developing your first product line or scaling up globally, our flexible production capabilities and collaborative approach will help you go further, faster.Insole ODM factory in Indonesia

📩 Contact us today to learn how our insole OEM, pillow ODM, and graphene product design services can elevate your product offering—while aligning with the sustainability expectations of modern consumers.Indonesia eco-friendly graphene material processing

Researchers have used advanced imaging to reveal how the protein fascin flexibly bundles actin filaments into hexagonal structures within filopodia, which are essential for cell movement but can also promote cancer metastasis. This discovery not only solves a decades-old puzzle about filopodia assembly but also offers new insights that could refine therapies targeting metastatic cancers. Credit: SciTechDaily.com Filopodia help cells move but also aid cancer spread. Scientists have revealed how fascin proteins build these structures, paving the way for better cancer treatments. Some of the body’s cells remain in place for life, while others are free to move. To travel, these migratory cells rely on filopodia—sensitive, finger-like protrusions that extend from the cell membrane into the surrounding environment. In a healthy cell, filopodia can be lifesaving, such as when an immune cell rushes to the site of an infection. However, they can also cause harm, as metastatic cancer cells use them to invade new areas of the body. Filopodia are made up of hexagonal bundles of proteins that provide structure and strength. For more than 40 years, scientists have struggled to understand how these intricate bundles assemble. Now, researchers at Rockefeller University’s Laboratory of Structural Biophysics and Mechanobiology have solved a major piece of that puzzle, using advanced imaging technology to reveal how the underlying proteins form these cohesive structures. The findings, published in Nature Structural & Molecular Biology, may improve some cancer treatments already in development, says first author Rui Gong, a research associate in the lab. “Understanding the structure of filopodia and the changes they undergo may help to refine these therapies or inspire new ones,” he says. Where else this discovery leads remains to be seen. The study marks the first time such a complex higher-order protein assembly has been imaged at the atomic level—a technological advance that other scientists can now use to study similarly complex configurations. “Until now, it hasn’t really been possible to visualize their internal structure in any significant detail,” says lab head Gregory M. Alushin. “Going forward, hopefully, we’ve made it easier to study these protein networks, where function emerges at the level of thousands of molecules.” The forces at work Alushin’s lab specializes in understanding the cytoskeleton—the network of protein filaments, including actin, that form a cell’s infrastructure. Actin serves many functions: it provides cells with an overall shape; helps them to generate and detect forces in their environments; facilitates the formation of axonal connections between cells; and enables cellular movement via filopodia. These dynamic protein strands bend and flex, crisscross each other, and even engage in tugs of war. But they only work collectively. A single actin filament is useless on its own. “It’s like a floppy noodle,” Alushin says. “It’s not very strong, and it can’t do anything. Actin filaments have to be gathered into higher-order assemblies such as bundles to carry out any useful job.” A hexagonal bundle of actin filaments linked together by fascin proteins. Credit: Laboratory of Structural Biophysics and Mechanobiology at The Rockefeller University One type of higher-order assembly is the hexagonal bundle found within filopodia. A protein called fascin binds and bridges pairs of actin filaments, stitching them into bundles. These bundles are then encased in long membrane tubes to form filopodia, which must be strong enough to protrude beyond the cell and yet malleable enough to sweep the environment. “They hit a sweet spot between strength and flexibility,” Alushin says. How fascins manage this assembly has been a “known unknown” for decades. In the 1970s, scientists tried to re-create hexagonal bundles by using wooden dowels representing actin filaments with small bits of wood representing fascin-like bridges interspersed between them. It was impossible to create a bundle without distorting the ersatz fascin. A better view More recently, high-imaging technologies such as cryo-EM and tomography enabled the first images of these bundles, but they were only blurry glimpses. For the current study, the researchers, co-led by Gong and former Rockefeller graduate student Matthew Reynolds, significantly improved upon an computational image analysis approach they developed in 2022 that involves “denoising” the images. The result was the first clear three-dimensional images of fascin proteins as they bridged actin filaments. “We saw real bundles composed of thousands of fascin molecules and hundreds of actin filaments, and we were able to map their spatial positioning,” Gong says. “We saw how the structure of fascin gives rise to its function as an actin bundler and figured out the detailed chemistry of its actin-binding sites.” One of the most surprising findings was that fascin is quite improvisational. There are many ways for the protein to build a bundle. Fascin may have evolved this skill because of the questionable construction materials it has to work with. “Because actin filaments are like twisty ribbons, they’re not great for building a firm hexagonal structure like you find in filopodia,” Gong notes. To overcome this problem, fascin has a structural flexibility that allows it to slip in between the filaments in a variety of places and fold itself into the shape needed to link them together. “A fascin protein can accommodate all kinds of imperfections. It acts like a molecular hinge that can hold a number of intermediary positions between open and closed. It can also rotate its position for a better fit,” Alushin says. “Despite being a small and ostensibly simple protein, it has very complicated physical behaviors.” Stopping filopodia in their tracks Fascin dysregulation is a clinical biomarker for metastatic cancer. In migratory cells, an overabundance of fascin leads to a filopodia-building frenzy, which can accelerate metastasis. And stationary cells with too much fascin gain an abnormal—and dangerous—ability to move. “When this overexpression happens in cells that should be locked into place, such as epithelial cells, they can build filopodia, which they’re not supposed to have,” Alushin says. “Then they can crawl away from their neighbors and in the process abandon their regular cellular functions.” Their findings may help improve the design and effectiveness of fascin inhibitors, which are currently in clinical trials, Gong adds. These inhibitors aim to halt metastasis by preventing fascin from binding actin filaments and gathering them into bundles within filopodia. Immobilized, the cancer cells are stopped in their tracks. It was thought that the inhibitors work by blocking fascin’s actin-binding sites, but the Rockefeller researchers discovered that instead, they prevent fascin from undergoing the shape changes needed to fit in its binding location—a new understanding that the team hopes could translate into clinical applications. “We’ve been able to detail essential design principles for the bundles, which could be really helpful information for finding new ways to interfere with their construction,” Alushin says. Reference: “Fascin structural plasticity mediates flexible actin bundle construction” by Rui Gong, Matthew J. Reynolds, Keith R. Carney, Keith Hamilton, Tamara C. Bidone and Gregory M. Alushin, 20 January 2025, Nature Structural & Molecular Biology. DOI: 10.1038/s41594-024-01477-2

Trypanosome cell during meiosis. Credit: Dr. Lori Peacock Researchers at the University of Bristol have discovered how microbes responsible for human African sleeping sickness produce sex cells. In these single-celled parasites, known as trypanosomes, each reproductive cell splits off in turn from the parental germline cell, which is responsible for passing on genes. Conventional germline cells divide twice to produce all four sex cells – or gametes – simultaneously. In humans, four sperms are produced from a single germline cell. So, these strange parasite cells are doing their own thing rather than sticking to the biology rulebook. Trypanosome cell biology has already revealed several curious features. They have two unique intracellular structures – the kinetoplast, a network of circular DNA and the glycosome, a membrane-enclosed organelle that contains the glycolytic enzymes. They don’t follow the central dogma that DNA is faithfully transcribed into RNA, but will go back and edit some of the RNA transcripts after they’ve been made. Trypanosome cell during meiosis producing the first gamete. Credit: Dr Lori Peacock Professor Wendy Gibson of the University of Bristol’s School of Biological Sciences led the study. She said “We’ve got used to trypanosomes doing things their own way, but of course what we think of as normal cell biology is based on very few so-called model organisms like yeast and mice. There’s a whole world of weird and wonderful single-celled organisms — protozoa — out there that we don’t know much about! Trypanosomes have got more attention because they’re such important pathogens — both of humans and their livestock.” Same image with superimposed images of DNA-containing nuclei and kinetoplasts in blue. Credit: Dr Lori Peacock Biologists think that sexual reproduction evolved very early on, after the first complex cells appeared a couple of billion years ago. The sex cells are produced by a special form of cell division called meiosis that reduces the number of chromosomes by half, so that gametes have only one complete set of chromosomes instead of two. The chromosome sets from two gametes combine during sexual reproduction, producing new combinations of genes in the offspring. In the case of disease-causing microbes like the trypanosome, sex can potentially lead to a lot of harmful genes being combined in one strain. Thus, research on sexual reproduction helps scientists understand how new strains of disease-causing microbes arise and how characteristics such as drug resistance get spread between different strains. Reference: “Sequential production of gametes during meiosis in trypanosomes” by Lori Peacock, Chris Kay, Chloe Farren, Mick Bailey, Mark Carrington and Wendy Gibson, 11 May 2021, Communications Biology. DOI: 10.1038/s42003-021-02058-5 The study was carried out by researchers from Bristol’s School of Biological Sciences and School of Veterinary Sciences in collaboration with the University of Cambridge.

A study by the University of Pittsburgh School of Medicine shows deep brain stimulation (DBS) may quickly improve arm and hand functions in stroke and traumatic brain injury patients. Testing on monkeys and humans indicates potential for DBS in rehabilitation, with ongoing research aimed at refining the treatment’s effectiveness and safety University of Pittsburgh researchers report that deep brain stimulation (DBS) can effectively enhance motor functions in individuals with arm and hand paralysis due to brain injuries, with promising results from early human and monkey trials. Researchers from the University of Pittsburgh School of Medicine have demonstrated that deep brain stimulation can immediately improve arm and hand strength and function weakened by traumatic brain injury or stroke. Initial trials in monkeys and a human patient showed promising results, opening a path for a new clinical application of an already widely used brain stimulation technology and offering insights into neural mechanisms underlying movement deficits caused by brain injury. “Arm and hand paralysis significantly impacts the quality of life of millions of people worldwide,” said senior and corresponding author Elvira Pirondini, Ph.D., assistant professor of physical medicine and rehabilitation at Pitt. “Currently, we don’t have effective solutions for patients who suffered a stroke or traumatic brain injury but there is a growing interest in the use of neurotechnologies that stimulate the brain to improve upper-limb motor functions.” The researchers reported their findings in the journal Nature Communications. Elvira Pirondini, Ph.D., assistant professor of physical medicine and rehabilitation at the University of Pittsburgh. Credit: Tim Betler, UPMC Neural Connections and Motor Control Brain lesions caused by serious brain trauma or stroke can disrupt neural connections between the motor cortex, a key brain region essential for controlling voluntary movement, and the muscles. Weakening of these connections prevents effective activation of muscles and results in movement deficits, including partial or complete arm and hand paralysis. Deep Brain Stimulation: A Promising Solution To boost the activation of existing, but weakened, connections, researchers proposed to use deep brain stimulation (DBS), a surgical procedure that involves placing tiny electrodes in specific areas of the brain to deliver electrical impulses that regulate abnormal brain activity. Over the past several decades, DBS has revolutionized the treatment of neurological conditions such as Parkinson’s disease by providing a way to control symptoms that were once difficult to manage with medication alone. “DBS has been life-changing for many patients. Now, thanks to ongoing advancements in the safety and precision of these devices, DBS is being explored as a promising option for helping stroke survivors recover their motor functions,” said senior author and surgical leader of the project, Jorge González-Martínez, M.D., Ph.D., professor and vice-chair of neurosurgery and director of the epilepsy and movement disorders program at Pitt. “It offers new hope to millions of people worldwide.” Jorge González-Martínez, M.D., Ph.D., professor and vice-chair of neurosurgery and director of the epilepsy and movement disorders program at the University of Pittsburgh. Credit: University of Pittsburgh Innovative Applications of DBS in Stroke Recovery Taking cues from another successful Pitt project that used electrical stimulation of the spinal cord to restore arm function in individuals affected by stroke, scientists hypothesized that stimulating the motor thalamus – a structure nested deep in the brain that acts as a key relay hub of movement control – using DBS could help restore movements that are essential for tasks of daily living, such as object grasping. However, because the theory has not been tested before, they first had to test it in monkeys, which are the only animals that have the same organization of the connections between the motor cortex and the muscles as humans. Clinical Trials and Human Application To understand the mechanism of how DBS of the motor thalamus helps improve voluntary arm movement and to finesse the specific location of the implant and the optimal stimulation frequency, researchers implanted the FDA-approved stimulation device into monkeys that had brain lesions affecting how effectively they could use their hands. As soon as the stimulation was turned on, it significantly improved the activation of muscles and grip force. Importantly, no involuntary movement was observed. To verify that the procedure could benefit humans, the same stimulation parameters were used in a patient who was set to undergo DBS implantation into the motor thalamus to help with arm tremors caused by brain injury from a serious motor vehicle accident that resulted in severe paralysis in both arms. As soon as the stimulation was turned on again, the range and strength of arm motion were immediately improved: The participant was able to lift a moderately heavy weight and reach, grasp, and lift a drinking cup more efficiently and smoothly than without the stimulation. Future Directions in Neurological Treatment To help bring this technology to more patients in the clinic, researchers are now working to test the long-term effects of DBS and determine whether chronic stimulation could further improve arm and hand function in individuals affected by traumatic brain injury or stroke. Reference: “Potentiation of cortico-spinal output via targeted electrical stimulation of the motor thalamus” by Jonathan C. Ho, Erinn M. Grigsby, Arianna Damiani, Lucy Liang, Josep-Maria Balaguer, Sridula Kallakuri, Lilly W. Tang, Jessica Barrios-Martinez, Vahagn Karapetyan, Daryl Fields, Peter C. Gerszten, T. Kevin Hitchens, Theodora Constantine, Gregory M. Adams, Donald J. Crammond, Marco Capogrosso, Jorge A. Gonzalez-Martinez and Elvira Pirondini, 1 October 2024, Nature Communications. DOI: 10.1038/s41467-024-52477-1 This research is supported by internal funding from the departments of Physical Medicine and Rehabilitation and of Neurological Surgery at Pitt. Additional funding was provided by the Walter L. Copeland Foundation, the Hamot Health Foundation, and the National Institutes of Health (R01NS122927-01A1).

DVDV1551RTWW78V